Spain Suspends Inmunotek Manufacturing Authorization for GMP Lapses

Drug Industry Daily
A A
Spain’s Agency of Medicines and Medical Devices has suspended the manufacturing authorization for finished processing of Madrid-based Inmunotek over GMP deficiencies.

To View This Article:

Login

Subscribe To Drug Industry Daily